dabigatran has been researched along with Hepatic Insufficiency in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, SH; Chu, PH; Kuo, CF; Tseng, HJ; Wang, CL; Wen, MS; Wu, VC | 1 |
Rathgen, K; Roth, W; Shakeri-Nejad, K; Stähle, H; Stangier, J | 1 |
1 trial(s) available for dabigatran and Hepatic Insufficiency
Article | Year |
---|---|
Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Area Under Curve; Benzimidazoles; Biological Availability; Blood Proteins; Dabigatran; Erythema; Female; Glucuronides; Half-Life; Headache; Hepatic Insufficiency; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Prodrugs; Prothrombin Time; Pyridines; Severity of Illness Index; Sex Factors; Thrombin | 2008 |
1 other study(ies) available for dabigatran and Hepatic Insufficiency
Article | Year |
---|---|
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hepatic Insufficiency; Humans; Male; Proportional Hazards Models; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Warfarin | 2018 |